Background: The genetics of syndromic hidradenitis suppurativa (HS), an immune-mediated condition associated with systemic comorbidities such as inflammatory bowel diseases and arthritis, has not been completely elucidated. Objective: To describe clinical features and genetic signature of patients with the main syndromic HS forms, i.e., PASH, PAPASH, and PASH/SAPHO overlapping. Methods: Whole-exome sequencing (WES) approach was performed in ten patients with syndromic HS. Results: Three clinical settings have been identified based on presence/absence of gut and joint inflammation. Four PASH patients who had also gut inflammation showed three different variants in NOD2 gene, two variants in OTULIN, and a variant in GJB2, respectively. Three PAPASH and three PASH/SAPHO overlapping patients who had also joint inflammation showed two different variants in NCSTN, one in WDR1 and PSTPIP1, and two variants in NLRC4, one of whom was present in a patient with a mixed phenotype characterized by gut and joint inflammation. Limitations: Limited number of patients that can be counterbalanced by the rarity of syndromic HS. Conclusion: Syndromic HS can be considered as a polygenic autoinflammatory condition; currently WES is a diagnostic tool allowing more accurate genotype-phenotype correlation.

1.
Canoui-Poitrine
F
,
Le Thuaut
A
,
Revuz
JE
,
Viallette
C
,
Gabison
G
,
Poli
F
,
Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study
.
J Invest Dermatol
.
2013
;
133
(
6
):
1506
11
.
2.
van der Zee
HH
,
Jemec
GB
.
New insights into the diagnosis of hidradenitis suppurativa: Clinical presentations and phenotypes
.
J Am Acad Dermatol
.
2015
;
73
:
S23
6
. .
3.
Martorell
A
,
Jfri
A
,
Koster
SBL
,
Gomez-Palencia
P
,
Solera
M
,
Alfaro-Rubio
A
,
Defining hidradenitis suppurativa phenotypes based on the elementary lesion pattern: results of a prospective study
.
J Eur Acad Dermatol Venereol
.
2020
;
34
(
6
):
1309
18
.
4.
Naasan
H
,
Affleck
A
.
Atypical hidradenitis suppurativa
.
Clin Exp Dermatol
.
2015
;
40
:
891
3
. .
5.
Cazzaniga
S
,
Pezzolo
E
,
Bettoli
V
,
Abeni
D
,
Marzano
AV
,
Patrizi
A
,
Characterization of Hidradenitis Suppurativa Phenotypes: A Multidimensional Latent Class Analysis of the National Italian Registry IRHIS
.
J Invest Dermatol
.
2021
;
141
(
5
):
1236
42.e1
.
6.
Garcovich
S
,
Genovese
G
,
Moltrasio
C
,
Malvaso
D
,
Marzano
AV
.
PASH, PAPASH, PsAPASH, and PASS: The autoinflammatory syndromes of hidradenitis suppurativa
.
Clin Dermatol
.
2020
.
7.
Gasparic
J
,
Theut Riis
P
,
Jemec
GB
.
Recognizing syndromic hidradenitis suppurativa: a review of the literature
.
J Eur Acad Dermatol Venereol
.
2017
;
31
:
1809
16
. .
8.
Tzellos
T
,
Zouboulis
CC
.
Review of Comorbidities of Hidradenitis Suppurativa: Implications for Daily Clinical Practice
.
Dermatol Ther (Heidelb)
.
2020
;
10
:
63
71
. .
9.
Marzano
AV
,
Damiani
G
,
Ceccherini
I
,
Berti
E
,
Gattorno
M
,
Cugno
M
.
Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis)
.
Br J Dermatol
.
2017
;
176
(
6
):
1588
98
. .
10.
Marzano
AV
,
Trevisan
V
,
Gattorno
M
,
Ceccherini
I
,
De Simone
C
,
Crosti
C
.
Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene
.
JAMA Dermatol
.
2013
;
149
(
6
):
762
4
. .
11.
Genovese
G
,
Caorsi
R
,
Moltrasio
C
,
Marzano
AV
.
Successful treatment of co-existent SAPHO syndrome and hidradenitis suppurativa with adalimumab and methotrexate
.
J Eur Acad Dermatol Venereol
.
2019
;
33 Suppl 6
:
40
1
. .
12.
Li
C
,
Xu
H
,
Wang
B
.
Is SAPHO Syndrome Linked to PASH Syndrome and Hidradenitis Suppurativa by Nicastrin Mutation? A Case Report
.
J Rheumatol
.
2018
;
45
:
1605
7
. .
13.
Cugno
M
,
Borghi
A
,
Marzano
AV
.
PAPA, PASH and PAPASH Syndromes: Pathophysiology, Presentation and Treatment
.
Am J Clin Dermatol
.
2017
;
18
:
555
62
. .
14.
Vural
S
,
Gundogdu
M
,
Kundakci
N
,
Ruzicka
T
.
Familial Mediterranean fever patients with hidradenitis suppurativa
.
Int J Dermatol
.
2017
;
56
(
6
):
660
3
. .
15.
Zouboulis
CC
,
Benhadou
F
,
Byrd
AS
,
Chandran
NS
,
Giamarellos-Buorboulis
EJ
,
Fabbrocini
G
,
What causes hidradenitis suppurativa?-15 years after
.
Exp Dermatol
.
2020
;
29
:
1154
70
.
16.
Frew
JW
,
Marzano
AV
,
Wolk
K
,
Join-Lambert
O
,
Alavi
A
,
Lowes
MA
,
A Systematic Review of Promising Therapeutic Targets in Hidradenitis Suppurativa: A Critical Evaluation of Mechanistic and Clinical Relevance
.
J Invest Dermatol
.
2021
;
141
(
2
):
316
24.e2
.
17.
Tricarico
PM
,
Boniotto
M
,
Genovese
G
,
Zouboulis
CC
,
Marzano
AV
,
An Integrated Approach to Unravel Hidradenitis Suppurativa Etiopathogenesis
.
Front Immunol
.
2019
;
2510
:
892
.
18.
Brandao
L
,
Moura
R
,
Tricarico
PM
,
Gratton
R
,
Genovese
G
,
Moltrasio
C
,
Altered keratinization and vitamin D metabolism may be key pathogenetic pathways in syndromic hidradenitis suppurativa: a novel whole exome sequencing approach
.
J Dermatol Sci
.
2020
;
99
:
17
22
.
19.
Marzano
AV
.
Hidradenitis suppurativa, neutrophilic dermatoses and autoinflammation: what's the link?
Br J Dermatol
.
2016
;
174
:
482
3
. .
21.
Picard tools – By Broad Institute. https://broadinstitute.github.io/picard/.
23.
Arteche-López
A
,
Ávila-Fernández
A
,
Romero
R
,
Riveiro-Álvarez
R
,
López-Martínez
MA
,
Giménez-Pardo
A
,
Sanger sequencing is no longer always necessary based on a single-center validation of 1109 NGS variants in 825 clinical exomes
.
Sci Rep
.
2021
;
11
:
5697
.
24.
McGovern
DP
,
van Heel
DA
,
Ahmad
T
,
Jewell
DP
.
NOD2 (CARD15), the first susceptibility gene for Crohn’s disease
.
Gut
.
2001
;
49
:
752
4
. .
25.
Yao
Q
,
Li
E
,
Shen
B
.
Autoinflammatory disease with focus on NOD2-associated disease in the era of genomic medicine
.
Autoimmunity
.
2019
;
52
:
48
56
. .
26.
van der Zee
HH
,
van der Woude
CJ
,
Florencia
EF
,
Prens
EP
.
Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study
.
Br J Dermatol
.
2010
;
162
:
195
7
. .
27.
Shalom
G
,
Freud
T
,
Ben Yakov
G
,
Khoury
R
,
Dreiher
J
,
Vardy
DA
,
Hidradenitis Suppurativa and Inflammatory Bowel Disease: A Cross-Sectional Study of 3,207 Patients
.
J Invest Dermatol
.
2016
;
136
:
1716
8
.
28.
Yada
S
,
Singh
S
,
Varayil
E
,
Harmsen
WS
,
Zinsmeister
AR
,
Tremaine
WJ
,
Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota
.
Clin Gastroenterol Hepatol
.
2016
;
14
:
6570
.
29.
Marzano
AV
,
Ishak
RS
,
Colombo
A
,
Caroli
F
,
Crosti
C
.
Pyoderma gangrenosum, acne and suppurative hidradenitis syndrome following bowel bypass surgery
.
Dermatology
.
2012
;
225
:
215
9
. .
30.
Garcovich
S
,
De Simone
C
,
Giovanardi
G
,
Robustelli
E
,
Marzano
AV
,
Peris
K
.
Post-bariatric surgery hidradenitis suppurativa: a new patient subset associated with malabsorption and micronutritional deficiencies
.
Clin Exp Dermatol
.
2019
;
44
:
283
9
. .
31.
Damgaard
RB
,
Walker
JA
,
Marco-Casanova
P
,
Morgan
NV
,
Titheradge
HL
,
Elliott
PR
,
The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity
.
Cell
.
2016
;
166
:
1215
30.e20
.
32.
Maintz
L
,
Betz
RC
,
Allam
JP
,
Wenzel
J
,
Jaksche
A
,
Friedrichs
N
,
Keratitis-ichthyosis-deafness syndrome in association with follicular occlusion triad
.
Eur J Dermatol
.
2005
;
15
:
347
52
.
33.
Vossen
ARJV
,
van Straalen
KR
,
Swagemakers
SMA
,
de Klein
JEMM
,
Stubbs
AP
,
Venter
DJ
,
A novel nicastrin mutation in a three-generation Dutch family with hidradenitis suppurativa: a search for functional significance
.
J Eur Acad Dermatol Venereol
.
2020
;
34
:
2353
61
.
34.
Duchatelet
S
,
Miskinyte
S
,
Join-Lambert
O
,
Ungeheuer
MN
,
Francès
C
,
Nassif
A
,
First nicastrin mutation in PASH (pyoderma gangrenosum, acne and suppurative hidradenitis) syndrome
.
Br J Dermatol
.
2015
;
173
:
610
2
.
35.
Kile
BT
,
Panopoulos
AD
,
Stirzaker
RA
,
Hacking
DF
,
Tahtamouni
LH
,
Willson
TA
,
Mutations in the cofilin partner Aip1/Wdr1 cause autoinflammatory disease and macrothrombocytopenia
.
Blood
.
2007
;
110
:
2371
80
.
36.
Canna
SW
,
de Jesus
AA
,
Gouni
S
,
Brooks
SR
,
Marrero
B
,
Liu
Y
,
An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome
.
Nat Genet
.
2014
;
46
:
1140
6
.
37.
Wise
CA
,
Gillum
JD
,
Seidman
CE
,
Lindor
NM
,
Veile
R
,
Bashiardes
S
,
Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder
.
Hum Mol Genet
.
2002
;
11
:
961
9
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.